Co-infection with Pansensitive and Multidrug-Resistant Strains ofMycobacterium tuberculosis
Open Access
- 1 April 2009
- journal article
- case report
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 15 (4), 578-580
- https://doi.org/10.3201/eid1504.080592
Abstract
We report a case of a 23-year-old HIV-negative man with multidrug-resistant Mycobacterium tuberculosis that became evident while he was being treated for M. tuberculosis that was sensitive to all first-line drugs. This case should alert clinicians to consider co-infection as a possible cause of recrudescent disease.Keywords
This publication has 13 references indexed in Scilit:
- Molecular Epidemiology of Tuberculosis: Current InsightsClinical Microbiology Reviews, 2006
- Variable host–pathogen compatibility in Mycobacterium tuberculosisProceedings of the National Academy of Sciences of the United States of America, 2006
- Molecular Epidemiology of TuberculosisThe New England Journal of Medicine, 2003
- Treatment of tuberculosis.2003
- A systematic review of the adjunctive use of systemic corticosteroids for pulmonary tuberculosis.2003
- Use of Molecular Techniques to Distinguish between Treatment Failure and Exogenous Reinfection withMycobacterium tuberculosisClinical Infectious Diseases, 2002
- HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkersThe Lancet, 2001
- Simultaneous Infection with Multiple Strains ofMycobacterium tuberculosisClinical Infectious Diseases, 2001
- Exogenous Reinfection with Tuberculosis on a European Island with a Moderate Incidence of DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Exogenous Reinfection as a Cause of Recurrent Tuberculosis after Curative TreatmentThe New England Journal of Medicine, 1999